FDA Approved Thermography Machine for Safe Breast Exams & Full Body Scans,
Over 30 years of research and 800 peer-reviewed studies encompassing well over 300,000 women participants has demonstrated thermography’s abilities in the early detection of breast cancer. Thermography provides a painless, noninvasive, non-ionizing, instant imaging procedure for the early detection and monitoring of a number of diseases and physical disorders including Breast Cancer, Thyroid, Vascular Disease and various Metabolic and Inflammatory Condition.
Natural Bio Health offers Thermography exams for all patients in Austin, Texas. Thermography is not just for Breast Cancer screening but has multiple purposes for both Men and Women. Inflammation, a leading cause and consequence of heart disease, cancer, diabetes, dementia, Alzheimer’s Disease, fibromyalgia, and many other disease processes, can be detected in its early stages with Thermography. The machine used by Natural Bio Health is the Spectron IR high resolution.
The Spectron IR high resolution (thermograph machine) is FDA approved for all of the following:
- Breast Cancer Screening
- Thyroid Abnormalities
- Peripheral Vascular Disease
- Neuromuscoskeletal Disorders
- Extracranial, Cerebral and Facial Vascular Disease
- Various Neoplastic, Metabolic, and Inflammatory Conditions
Thermography provides a painless, noninvasive, non-ionizing, instant imaging procedure for the early detection and monitoring of a number of diseases and physical disorders. Unlike mammograms, it does not use harmful radiation and breast tissue density does not affect its value.
Comments From Dr. Feste
Although mammograms have been the standard of care for detecting breast cancer, there are many studies showing the dangers associated with Mammograms. For example, mammograms have 4 times the amount of radiation exposure of a chest X-ray even though both are consider low dose radiation. There is some evidence that low dose radiation carries a higher risk versus higher dose radiation of the past.
Mammography is not well suited for women with dense breasts, implants, fibrocystic breast, or on hormone therapy. There is also a risk of rupture of the encapsulation of a cancerous tumor and release malignant cells into the blood stream. Twenty two pounds of pressure is sufficient to rupture the encapsulation around a cancerous tumor but todays mammogram equipment uses forty-two (42) pounds of pressure.
I recommend Thermography testing for its safety, effectiveness and its many uses. Thermography has been shown to have a sensitivity of 83% in detecting breast cancer. Screening with thermography should be considered first. In the case of suspicious lesions, mammography may be added to increase sensitivity.
Early Detection and Warning Signs of Breast Cancer.
Because of thermography’s unique ability to image the thermovascular aspects of the breast, extremely early warning signals have been observed in long-term studies. Consequently, thermography is the earliest known indicator for the future development of breast cancer. It is for this reason that an abnormal infrared image is the single most important marker of high risk for developing breast cancer. Thus, thermography has a significant place as one of the major front-line methods of breast cancer detection.
The large patient populations and long survey periods in many of the clinical studies yields a high significance to the various statistical data obtained. This is especially true for the contribution of thermography to early cancer diagnosis, as an invaluable marker of high-risk populations, and therapeutic decision making (a contribution that has been established and justified by the unequivocal relationship between heat production and tumor doubling time).
Currently available high-resolution digital infrared imaging (Thermography) technology benefits greatly from enhanced image production, standardized image interpretation protocols, computerized comparison and storage, and sophisticated image enhancement and analysis. Over 30 years of research and 800 peer-reviewed studies encompassing well over 300,000 women participants has demonstrated thermography’s abilities in the early detection of breast cancer. Ongoing research into the thermal characteristics of breast pathologies will continue to investigate the relationships between neoangiogenesis, chemical mediators, and the neoplastic process.
It is unfortunate, but many physicians still hesitate to consider thermography as a useful tool in clinical practice in spite of the considerable research database, continued improvements in both thermographic technology and image analysis, and continued efforts on the part of the thermographic societies. This attitude may be due to the fact that the physical and biological bases of thermography are not familiar to most physicians. The other methods of cancer investigations refer directly to topics of medical teaching. For instance, radiography and ultrasonography refer to anatomy. Thermography, however, is based on thermodynamics and thermokinetics, which are unfamiliar to most physicians, though man is experiencing heat production and exchange in every situation he undergoes or creates.
Numerous studies have been published in the United States, England and France demonstrating that patients in the false positive thermographic group, those patients with positive thermograms and negative mammograms who were told the thermography was wrong, were determined by long term follow-up to have developed breast cancer in exactly the location thermography had demonstrated its positive finding 5-10 years earlier.
Thermography’s only error is that it is too right ~ too early. It is our job as scientists, physicians and concerned patients, to identify the appropriate protocols once a thermogram is positive. It is in this capacity that the paradigm must shift. I was fortunate to utilize in my practice in the early 1970’s thermography with devices that are far inferior to those available today. Both infra-red technology and capturing imges and interpretation of images have progressed exponentially over the last 41 years. We still have to use all of our knowledge and devices to be able to provide an early diagnosis and cure cancer of the breast.